Showing posts with label inhaled corticosteroids. Show all posts
Showing posts with label inhaled corticosteroids. Show all posts

Thursday, 24 September 2009

John Hopkins experts call for greater caution for prescribing inhaled corticosteroids

Lung disease experts at Johns Hopkins have made a call for greater caution for prescribing inhaled corticosteroids to people suffering from chronic obstructive pulmonary disease (COPD). The call came after sufficient evidence was found by the experts that inhaled corticosteroids enhance the risk of pneumonia by a full third.
It is believed that more than 11 million Americans are living with COPD and a vast majority of this population belongs to the former or current smokers' category.
From News-Medical.Net:
Despite the increased pneumonia risk, the team found no clear evidence that the drug therapy also pushes up rates for other steroid-related problems, such as bone fractures, nor was there an increase in deaths.
Senior study investigator and critical care specialist Eddy Fan, M.D., says the results of the analysis should not alarm patients or cause them to stop taking their medications but should spur physicians to screen and monitor their patients to find the lowest possible steroid dose that works, especially in the elderly, people with immune system problems, and people who have had multiple bouts of pneumonia and for whom repeat bacterial infection might be a life-threatening complication.
"Inhaled corticosteroids are not of equal benefit to all, and what we are seeing is that the treatment may be more harmful and pose a greater risk of harm to some," says Fan, an instructor at the Johns Hopkins University School of Medicine.
According to pulmonologist M. Brad Drummond, M.D., M.H.S., who led the study, the findings are seen to serve as a reminder for all those people with serious lung disease to take steps for ensuring a reduction concerned with chances of getting pneumonia, which doubles their risk of dying.

Saturday, 20 June 2009

Steroid Nasal Spray Works Better Than Oral Antihistamine

In a research conducted by the team of Dr. Robert Naclerio of the University of Chicago found out that steroid nasal spray is more effective than the usual inhaled corticosteroids and antihistamine in treating seasonal allergies.

The researchers compared the effectiveness of fluticasone (Flonase),a corticosteroid nasal spray, with loratadine (Claritin),a nonsedating antihistamine, for treating ragweed allergy on an as-needed basis. The team found out that participants who used the inhaled steroid experienced significantly fewer allergy symptoms and reported less impact on their quality of life than those who took the antihistamine.

From Bio-Medicine:

Researchers say that a steroid nasal spray may relieve seasonal allergy symptoms better than an oral antihistamine.

During the four-week study, 88 participants took either the steroid nasal spray or antihistamine on an as-needed basis. They kept a daily diary of their allergy symptoms and completed a quality-of-life questionnaire.

Researchers looked for chemical evidence of allergic reaction, such as eosinophils, in participants' blood. Eosinophils are white blood cells involved in defending the body from allergens. For best results, experts generally recommend that you use either an inhaled steroid or an antihistamine on a continuous, long-term basis.

But the researchers point out that most people tend to wait until symptoms appear before taking allergy medications. This may be one reason for the superiority of the steroid nasal spray in the study. Unlike inhaled corticosteroids, antihistamines like Claritin are not very effective in blocking the allergic response once it has begun.

Although antihistamine and inhaled corticosteroids are the usual treatments given to relieve allergic symptoms, researchers claim that these treatments are less effective in addressing the condition. These treatments are found to be ineffective in treating allergic symptoms especially if they have started to manifest. The team suggests that steroid nasal spray should only be used on an as needed basis.

Tuesday, 16 June 2009

COPD Patients to benefit from Inhaled Corticosteroids

As per a new study published in the CHEST, a peer-reviewed journal of the American College of Chest Physicians, COPD (Chronic obstructive pulmonary disease) patients using inhaled corticosteroids are believed to have a decreased mortality risk than who do not use them.

The survival is longer in patients with COPD who make use of inhaled corticosteroids, as per Christine Macie, MD, FCCP, Cambridge Hospital, Ontario, Canada and author of this study.

From Bio-medicine.org:

“Our results indicate that the effect of inhaled corticosteroids is relatively short-term and that those currently using it are relatively better protected, ” said Dr. Macie. “Inhaled corticosteroids should be prescribed as soon as clinically indicated. By treating COPD with inhaled corticosteroids, we have the potential to reduce the effect and prolong life.”

“The findings from this study are intriguing for clinicians and point to the need for further research to define the role and mechanisms of the effect of inhaled corticosteroids on both cardiovascular and respiratory mortality,” said W. Michael Alberts, MD, FCCP, President of the ACCP.

During the study, it was found that COPD patients being administered with inhaled corticosteroids within 30 days of their hospital discharge had a 25 percent reduced all-cause mortality rate. In addition to that, cardiovascular related mortality reduced by as much as 38 percent in COPD patients using corticosteroids in pair with beta-agonists.

Dr. Macie also said that COPD Patients making use of inhaled corticosteroids are relatively better protected than those who are not making a use of it.